期刊文献+

结直肠癌组织中PI3KCB蛋白表达及其与多药耐药基因产物的相关性 被引量:4

Expression of PI3KCB and its relationship with multidrug resistance gene products in colorectaI carcinoma tissues
下载PDF
导出
摘要 目的观察PI3KCB蛋白在结直肠癌组织中的表达情况,并探讨其与结直肠癌多药耐药(MDR)基因产物的相关性。方法采用免疫组化SP法检测128例结直肠癌组织、10例正常结肠黏膜组织中的PI3KCB蛋白及MDR基因产物LRP、GST-π、TopoⅡ。结果结直肠癌组织中PI3KCB蛋白呈阳性表达者105例(82.03%),正常结肠黏膜组织呈阳性表达者1例(10.00%),两者相比,P<0.01。结直肠癌组织中PI3KCB蛋白的表达与肿瘤发生部位、分化程度、临床分期及淋巴结转移有关(P均<0.05)。结直肠癌组织中LRP、GST-π、TopoⅡ呈阳性表达者分别为106例(82.81%)、120例(93.75%)、68例(53.13%),PI3KCB蛋白的表达与GST-π的表达呈正相关(rs=0.207,P<0.05)。结论 PI3KCB在结直肠癌组织中表达增加,与结直肠癌的发生发展及MDR密切相关;检测PI3KCB蛋白对于判断结直肠癌的生物学行为以及合理筛选有效的化疗药物具有重要参考价值。 Objective To investigate the expression of PI3KCB protein and its relationship with muhidrug resistance (MDR) gene products in colorectal carcinoma tissues. Methods The PI3KCB, LRP, GST-π and Topo II was detected by immunohistochemistry in 10 samples of normal colorectal mucosal tissues,and 128 samples of colorectal carcinoma tissues. Results One ( 10.0% ) case in normal colorectal mucosal tissues and 105 ( 82.03% ) cases in colorectal carcinoma tis- sues, the PI3KCB protein was positive, there were statistical differences (P 〈 0.01 ), it also correlated with the position, metastasis and TNM staging of colorectal carcinoma ( all P 〈 0.05). In colorectal carcinoma, the LRP was positive in 106 (82.81%) cases, GST-π was positive in 120 (93.75%) cases, Topo II was positive in 68 (53.13%) cases respectively. The expression of PI3KCB protein was positively correlated with GST-π expression in colorectal carcinoma (r8 = 0.207 ,P 〈 0.05). Conclusions The expression of PI3KCB protein is rasied in colorectal carcinoma tissues, it correlates with tumori- genesis, development, and MDR of colorectal carcinoma. The detection of PI3KCB protein is important for patients with colorectal carcinoma in prognosis and optimal therapy.
机构地区 滨州医学院
出处 《山东医药》 CAS 2012年第14期7-9,共3页 Shandong Medical Journal
基金 山东省科技发展计划项目(2010GSF10259)
关键词 PI3KCB蛋白 结肠肿瘤 直肠肿瘤 多药耐药 PI3KCB protein colonic neoplasms rectal neoplasms muhidrug resistance
  • 相关文献

参考文献10

二级参考文献68

共引文献52

同被引文献51

  • 1刘韦成,王桂华,曹小年,罗学来,李兆明,邓豫,李小兰,王诗佳,刘梦菲,胡俊波,王晶.Down-regulation of p110β Expression Increases Chemosensitivity of Colon Cancer Cell Lines to Oxaliplatin[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2012,32(2):280-286. 被引量:1
  • 2Kyle J Napier,Mary Scheerer,Subhasis Misra.Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities[J].World Journal of Gastrointestinal Oncology,2014,6(5):112-120. 被引量:97
  • 3Laurent-Puiq P,Aqostini J,Maley K. Colorectaloncogenesis[J].Bulletin Du Cancer,2010,(11):1311-1321.
  • 4Izycka-Swieszewska E,Brzeskwiniewicz M,Wozniak A. EGFR,PIK3CA and PTEN gene status and their protein product expression in neuroblastic tumours[J].Folia Neuro Pathol,2010,(04):238-245.
  • 5Dbouk H A,Backer J M. A beta version of life:p110β takes center stage[J].Oncotarget,2010,(08):729-733.
  • 6Carnero A,Blanco-Aparicio C,Renner O. The PTEN/PI3K/AKT signalling pathway in cancer,therapeutic implications[J].Current Cancer Drug Targets,2008,(03):187-198.doi:10.2174/156800908784293659.
  • 7Yuan T L,Cantley L C. PI3K pathway alterations in cancer:variations on a theme[J].Oncogene,2008,(41):5497-5510.doi:10.1038/onc.2008.245.
  • 8Xing M. Recent advances in molecular biology of thyroid cancer and their clinical implications[J].Otolaryngologic Clinics of North America,2008,(06):1135-1146.
  • 9Zhao L,Vogt P K. Helical domain and kinase domain mutations in p110 of Phosphate-dylinositol 3-kinase induce gain of function by differert mechanisms[J].Proceedings of the National Academy of Sciences(USA),2008,(07):2652-2657.
  • 10Hutti J E,Pfefferle A D,Russell S C. Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation[J].Cancer Research,2012,(13):3260-3269.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部